According to our market capitalization data, Eli Lilly (LLY) reached a market cap of $678.07 billion, securing the top spot among global Biotech companies. Novo Nordisk A/S (NOVO-B.CO) and Johnson & Johnson (JNJ) follow closely behind. The data was last updated on January 23, 2025.
Rank | Name | Market Cap | Price | MCap(30D) | MCap(1Y) | Country |
---|---|---|---|---|---|---|
801
|
NuCana
NCNA
|
$4.36 M | $1.11 |
-13.5%
|
-84.2%
|
United Kingdom
|
802
|
Gamida Cell
GMDA
|
$4.34 M | $0.03 |
0.00%
|
-95.1%
|
Israel
|
803
|
Integragen SA
ALINT.PA
|
$4.31 M | $0.62 |
12.3%
|
-23.9%
|
France
|
804
|
MyMD Pharmaceuticals
MYMD
|
$4.31 M | $1.33 |
0.00%
|
-74.3%
|
United States
|
805
|
Vincerx Pharma
VINC
|
$4.06 M | $0.11 |
-17.4%
|
-86.7%
|
United States
|
806
|
Acticor Biotech SAS
ALACT.PA
|
$4.04 M | $0.26 |
0.00%
|
-94.9%
|
France
|
807
|
Oragenics
OGEN
|
$3.90 M | $0.28 |
-28.2%
|
-94.3%
|
United States
|
808
|
Tharimmune
THAR
|
$3.87 M | $2.00 |
-5.6%
|
-69.2%
|
United States
|
809
|
Gritstone bio
GRTS
|
$3.80 M | $0.01 |
0.00%
|
-99.5%
|
United States
|
810
|
Avalon GloboCare
ALBT
|
$3.72 M | $3.40 |
3.1%
|
-42.6%
|
United States
|
811
|
Genetic Technologies
GENE
|
$3.71 M | $0.76 |
0.00%
|
-63.4%
|
Australia
|
812
|
Sonoma Pharmaceuticals
SNOA
|
$3.48 M | $2.60 |
-3.6%
|
-22.1%
|
United States
|
813
|
Lipella Pharmaceuticals
LIPO
|
$3.45 M | $2.85 |
-14.2%
|
-65.1%
|
United States
|
814
|
Monsenso A/S
MONSO.CO
|
$3.40 M | $0.05 |
0.00%
|
31.7%
|
Denmark
|
815
|
Azitra
AZTR
|
$3.33 M | $0.27 |
-39.5%
|
-99.4%
|
United States
|
816
|
Biophytis S.A.
ALBPS.PA
|
$3.24 M | $0.31 |
-18.8%
|
-84.6%
|
France
|
817
|
Vaccinex
VCNX
|
$3.24 M | $1.21 |
-1.8%
|
-86.5%
|
United States
|
818
|
Titan Pharmaceuticals
TTNP
|
$3.11 M | $3.40 |
6.4%
|
-31.2%
|
United States
|
819
|
Petros Pharmaceuticals
PTPI
|
$3.10 M | $0.31 |
-3.5%
|
-73.9%
|
United States
|
820
|
Rapid Nutrition PLC
ALRPD.PA
|
$2.97 M | $0.04 |
-11.1%
|
-36.0%
|
United Kingdom
|
821
|
Matinas BioPharma
MTNB
|
$2.92 M | $0.57 |
9.1%
|
-94.2%
|
United States
|
822
|
Brain+ A/S
BRAINP.CO
|
$2.87 M | $0.01 |
2.8%
|
-52.8%
|
Denmark
|
823
|
Talis Biomedical
TLIS
|
$2.86 M | $1.57 |
11.8%
|
-75.8%
|
United States
|
824
|
Alaunos Therapeutics
TCRT
|
$2.74 M | $1.71 |
-4.8%
|
-93.7%
|
United States
|
825
|
PainReform
PRFX
|
$2.69 M | $3.07 |
-39.0%
|
-75.8%
|
Israel
|
826
|
Biora Therapeutics
BIOR
|
$2.53 M | $0.22 |
-50.4%
|
-97.6%
|
United States
|
827
|
iSpecimen
ISPC
|
$2.20 M | $2.29 |
-17.4%
|
-75.7%
|
United States
|
828
|
VBI Vaccines
VBIV
|
$1.87 M | $0.01 |
0.00%
|
-97.4%
|
United States
|
829
|
BBS-Bioactive Bone Substitutes Oyj
BONEH.HE
|
$1.76 M | $0.06 |
15.0%
|
-86.7%
|
Finland
|
830
|
Trevena
TRVN
|
$1.61 M | $1.86 |
2.8%
|
-88.4%
|
United States
|
831
|
Advaxis
ADXS
|
$1.28 M | $0.03 |
0.00%
|
-95.5%
|
United States
|
832
|
Altamira Therapeutics
CYTO
|
$1.13 M | $0.17 |
112.5%
|
-92.5%
|
|
833
|
Evofem Biosciences
EVFM
|
$1.00 M | $0.01 |
11.1%
|
-66.7%
|
United States
|
834
|
Hepion Pharmaceuticals
HEPA
|
$0.94 M | $0.14 |
-5.3%
|
-76.4%
|
United States
|
835
|
Lucy Scientific Discovery
LSDI
|
$0.91 M | $0.02 |
0.00%
|
-99.0%
|
Canada
|
836
|
Telesis Bio
TBIO
|
$0.53 M | $0.30 |
-5.2%
|
-94.0%
|
United States
|
837
|
Yield10 Bioscience
YTEN
|
$0.35 M | $0.00 |
-99.7%
|
-100.0%
|
United States
|
838
|
PaxMedica
PXMD
|
$0.34 M | $0.03 |
-55.1%
|
-93.8%
|
United States
|
839
|
Seelos Therapeutics
SEEL
|
$0.21 M | $0.02 |
-91.3%
|
-100.0%
|
United States
|
840
|
Bellerophon Therapeutics
BLPH
|
$0.15 M | $0.01 |
-78.2%
|
-62.5%
|
United States
|
841
|
Vaxxinity
VAXX
|
$0.06 M | $0.00 |
33.3%
|
-99.9%
|
United States
|
842
|
Neovacs SA
ALNEV.PA
|
$0.06 M | $0.53 |
-54.4%
|
-100.0%
|
France
|
843
|
Calithera Biosciences
CALA
|
$0.00 M | $0.00 |
100.0%
|
-99.3%
|
United States
|
844
|
eFFECTOR Therapeutics
EFTR
|
$0.00 M | $0.00 |
0.00%
|
-100.0%
|
United States
|